"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Descriptor ID |
D023903
|
| MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
| Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 01 01; 162:24-30.
-
Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
-
Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging. 2019 May; 35(5):759-760.
-
Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials. Cardiovasc Revasc Med. 2019 07; 20(7):612-618.
-
Drug-coated balloons: "Do they still have a role in treating coronary artery disease?" Catheter Cardiovasc Interv. 2017 09 01; 90(3):387-388.
-
Bioresorbable Scaffold: The Emerging Reality and Future Directions. Circ Res. 2017 Apr 14; 120(8):1341-1352.
-
Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Cardiovasc Revasc Med. 2017 Apr - May; 18(3):169-176.
-
Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty. Catheter Cardiovasc Interv. 2015 Aug; 86(2):199-208.
-
Comparison of scanning electron microscopy and optical coherence tomography for imaging of coronary bifurcation stents. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1141-9.
-
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.